BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12075401)

  • 1. Diagnosis of gastrointestinal stromal tumors: a consensus approach.
    Fletcher CD; Berman JJ; Corless C; Gorstein F; Lasota J; Longley BJ; Miettinen M; O'Leary TJ; Remotti H; Rubin BP; Shmookler B; Sobin LH; Weiss SW
    Int J Surg Pathol; 2002 Apr; 10(2):81-9. PubMed ID: 12075401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of gastrointestinal stromal tumors: A consensus approach.
    Fletcher CD; Berman JJ; Corless C; Gorstein F; Lasota J; Longley BJ; Miettinen M; O'Leary TJ; Remotti H; Rubin BP; Shmookler B; Sobin LH; Weiss SW
    Hum Pathol; 2002 May; 33(5):459-65. PubMed ID: 12094370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.
    de Silva CM; Reid R
    Pathol Oncol Res; 2003; 9(1):13-9. PubMed ID: 12704441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution.
    Dei Tos AP
    Virchows Arch; 2003 May; 442(5):421-8. PubMed ID: 12759750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.
    Kitamura Y; Hirota S; Nishida T
    Cancer Sci; 2003 Apr; 94(4):315-20. PubMed ID: 12824897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
    Demetri GD
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of KIT in the management of patients with gastrointestinal stromal tumors.
    Hornick JL; Fletcher CD
    Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.
    Koh JS; Trent J; Chen L; El-Naggar A; Hunt K; Pollock R; Zhang W
    Histol Histopathol; 2004 Apr; 19(2):565-74. PubMed ID: 15024716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.
    Miettinen M; El-Rifai W; H L Sobin L; Lasota J
    Hum Pathol; 2002 May; 33(5):478-83. PubMed ID: 12094372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development.
    Demetri GD
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1115-24. PubMed ID: 12512386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of gastrointestinal stromal tumors: before and after STI-571.
    Dematteo RP; Heinrich MC; El-Rifai WM; Demetri G
    Hum Pathol; 2002 May; 33(5):466-77. PubMed ID: 12094371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
    Gold JS; Dematteo RP
    Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].
    Mac K; Wójcik M
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors--a review.
    Joensuu H; Kindblom LG
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):62-71. PubMed ID: 15188667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and biological overview of gastrointestinal stromal tumors.
    Candelaria M; de la Garza J; Duenas-Gonzalez A
    Med Oncol; 2005; 22(1):1-10. PubMed ID: 15750190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib.
    Cormier JN; Patel SR; Pisters PW
    Curr Oncol Rep; 2002 Nov; 4(6):504-9. PubMed ID: 12354363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Imatinib--a breakthrough in the treatment of gastrointestinal stromal tumors (GIST)].
    Larsen JB
    Ugeskr Laeger; 2003 Sep; 165(37):3503-7. PubMed ID: 14531349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumors: chemotherapy and imatinib.
    Muler JH; Baker L; Zalupski MM
    Curr Oncol Rep; 2002 Nov; 4(6):499-503. PubMed ID: 12354362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor.
    Kleinbaum EP; Lazar AJ; Tamborini E; Mcauliffe JC; Sylvestre PB; Sunnenberg TD; Strong L; Chen LL; Choi H; Benjamin RS; Zhang W; Trent JC
    Int J Cancer; 2008 Feb; 122(3):711-8. PubMed ID: 17943734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.